Argenx Se (ARGX) EBIT Growth (1y) (2017 - 2026)
Argenx Se (ARGX) EBIT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 183.45% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1,386.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.45% |
| Dec 31, 2025 | 256.76% |
| Sep 30, 2025 | 2,340.22% |
| Jun 30, 2025 | 542.27% |
| Mar 31, 2025 | 248.79% |
| Dec 31, 2024 | 174.33% |
| Sep 30, 2024 | 117.60% |
| Jun 30, 2024 | 55.47% |
| Mar 31, 2024 | 9.95% |
| Dec 31, 2023 | -21.14% |
| Sep 30, 2023 | 61.37% |
| Jun 30, 2023 | 41.51% |
| Mar 31, 2023 | 53.42% |
| Dec 31, 2022 | 50.44% |
| Sep 30, 2022 | -3,036.48% |
| Jun 30, 2022 | -100.00% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | -68.75% |
| Sep 30, 2021 | 105.99% |
| Jun 30, 2021 | 3,961,320,254.47% |